Compared to the control group, the absolute number of NKT (NK1.1+αβTCR+) and γδT cells in the MLN significantly decreased in the IL-33-treated chronic colitis group, while the percentage of NKT (NK1.1+αβTCR+) and γδT cells showed no differences in the two groups. This evidence concerns the gene IL33 and Chronic colitis.